Seeing Is Believing
Currently out of the existing stock ratings of Kevin Caliendo, 236 are a BUY (51.3%), 14 are a SELL (3.04%), 210 are a HOLD (45.65%).
Analyst Kevin Caliendo, currently employed at UBS, carries an average stock price target met ratio of 70.19% that have a potential upside of 19.87% achieved within 265 days.
Kevin Caliendo’s has documented 905 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Communication Services sectors.
Most recent stock forecast was given on NVST, Envista Holdings Corp at 17-Sep-2026.
Analyst best performing recommendations are on GDRX (GOODRX HOLDINGS).
The best stock recommendation documented was for CVS (CVS HEALTH CORP) at 2/10/2025. The price target of $59 was fulfilled within 2 days with a profit of $7.48 (14.52%) receiving and performance score of 72.59.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Feb-2018
$215
$40.04 (22.89%)
$187
3 years 1 months 25 days ago
(07-Aug-2023)
15/16 (93.75%)
$28.91 (15.54%)
636
Hold Since 27-May-2022
$190
$15.04 (8.60%)
$176
3 years 1 months 29 days ago
(03-Aug-2023)
12/12 (100%)
$-0.86 (-0.45%)
392
Buy Since 11-Oct-2022
$215
$40.04 (22.89%)
$200
3 years 1 months 29 days ago
(03-Aug-2023)
7/10 (70%)
$24.14 (12.65%)
211
Buy Since 05-Aug-2021
$220
$45.04 (25.74%)
$213
3 years 1 months 29 days ago
(03-Aug-2023)
11/17 (64.71%)
$29.14 (15.27%)
326
$190
$15.04 (8.60%)
3 years 1 months 29 days ago
(03-Aug-2023)
9/9 (100%)
$-0.86 (-0.45%)
440
Which stock is Kevin Caliendo most bullish on?
Which stock is Kevin Caliendo most reserved on?
What Year was the first public recommendation made by Kevin Caliendo?